Related references
Note: Only part of the references are listed.Bioresponsive drug delivery systems in intestinal inflammation: State-of-the-art and future perspectives
Niranjan G. Kotla et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease
Mahira Zeeshan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles
Kevin Ling et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses
Daniele Piovani et al.
GASTROENTEROLOGY (2019)
Therapeutic effect of gold nanoparticles on DSS-induced ulcerative colitis in mice with reference to interleukin-17 expression
Amira M. Abdelmegid et al.
SCIENTIFIC REPORTS (2019)
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives
Chunhua Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination
Robin Augustine et al.
ACTA BIOMATERIALIA (2018)
Anti-inflammatory effects of sinapic acid on 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice
Ji-Yun Lee
ARCHIVES OF PHARMACAL RESEARCH (2018)
Preparation, characterization, and pharmacokinetics of liposomal docetaxel for oral administration
Jung Ha Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease
Murtada A. Oshi et al.
CARBOHYDRATE POLYMERS (2018)
Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis
Mingzhen Zhang et al.
INFLAMMATORY BOWEL DISEASES (2018)
Colon-targeted delivery of cyclosporine A using dual-functional Eudragit (R) FS30D/PLGA nanoparticles ameliorates murine experimental colitis
Muhammad Naeem et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions
Muhammad Naeem et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Biodistribution and targeting potential assessment of mucoadhesive chitosan nanoparticles designed for ulcerative colitis via scintigraphy
Pooja Mongia Raj et al.
RSC ADVANCES (2018)
Macropored microparticles with a core-shell architecture for oral delivery of biopharmaceuticals
Bahman Homayun et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Aptamer-Conjugated Apigenin Nanoparticles To Target Colorectal Carcinoma: A Promising Safe Alternative of Colorectal Cancer Chemotherapy
Debasmita Dutta et al.
ACS APPLIED BIO MATERIALS (2018)
Application Potential of Polymeric Nanoconstructs for Colon-Specific Drug Delivery
Sanjay Kumar Jain et al.
MULTIFUNCTIONAL NANOCARRIERS FOR CONTEMPORARY HEALTHCARE APPLICATIONS (2018)
Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications
Hima Bindu Ruttala et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model
Ana Melero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Gut Fermentation of Dietary Fibres: Physico-Chemistry of Plant Cell Walls and Implications for Health
Barbara A. Williams et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chitosan-zein nano-in-microparticles capable of mediating in vivo transgene expression following oral delivery
Eric Farris et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Broccoli-Derived Nanoparticle Inhibits Mouse Colitis by Activating Dendritic Cell AMP-Activated Protein Kinase
Zhongbin Deng et al.
MOLECULAR THERAPY (2017)
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis
Bo Xiao et al.
MOLECULAR THERAPY (2017)
Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis
Mingzhen Zhang et al.
NANOMEDICINE (2017)
Solid lipid nanoparticles delivering anti- inflammatory drugs to treat inflammatory bowel disease: Effects in an in vivo model
Chiara Dianzani et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Adherence in ulcerative colitis: an overview
Anna Testa et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease
Hongzhi Qiao et al.
DRUG DELIVERY (2017)
Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives
Antara Banerjee et al.
DRUG DISCOVERY TODAY (2017)
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
Mingzhen Zhang et al.
BIOMATERIALS (2016)
A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease
Qixiong Zhang et al.
BIOMATERIALS (2016)
A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease
Ana Beloqui et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Liposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitro
Wei-liang Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Nanotechnologies for the treatment of colon cancer: From old drugs to new hope
Larissa Kotelevets et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo
Annika Frede et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Role of nanoparticle size, shape and surface chemistry in oral drug delivery
Amrita Banerjee et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery
Lin Zhang et al.
JOURNAL OF DRUG TARGETING (2016)
Positively Charged Surface-Modified Solid Lipid Nanoparticles Promote the Intestinal Transport of Docetaxel through Multifunctional Mechanisms in Rats
Li-Li Shi et al.
MOLECULAR PHARMACEUTICS (2016)
Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy
Mingzhen Zhang et al.
MOLECULAR THERAPY (2016)
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease
Xiao-Ying Si et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Polymeric nanoparticles for colon cancer therapy: overview and perspectives
Xinru You et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Colon-Targeted Oral Drug Delivery Systems: Design Trends and Approaches
Seth Amidon et al.
AAPS PHARMSCITECH (2015)
N-Trimethyl Chitosan Chloride-Coated PLGA Nanoparticles Overcoming Multiple Barriers to Oral Insulin Absorption
Jianyong Sheng et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent
Wooseong Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer
Long Binh Vong et al.
BIOMATERIALS (2015)
Understanding the colon cancer stem cells and perspectives on treatment
Elsa N. Garza-Trevino et al.
CANCER CELL INTERNATIONAL (2015)
The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery
Yiming Ma et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Probing the interaction of nanoparticles with mucin for drug delivery applications using dynamic light scattering
Peter Charles Griffiths et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles
Muhammad Naeem et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Specific accumulation of orally administered redox nanotherapeutics in the inflamed colon reducing inflammation with dose-response efficacy
Long Binh Vong et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Effect of surface chemistry on nanoparticle interaction with gastrointestinal mucus and distribution in the gastrointestinal tract following oral and rectal administration in the mouse
Katharina Maisel et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap® System
Mirko Koziolek et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue
Susan Hua et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer
Shashank Tummala et al.
SAUDI PHARMACEUTICAL JOURNAL (2015)
Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy
Muhammad Naeem et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K. Tsilidis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Co-delivery of camptothecin and curcumin by cationic polymeric nanoparticles for synergistic colon cancer combination chemotherapy
Bo Xiao et al.
JOURNAL OF MATERIALS CHEMISTRY B (2015)
Potential functional applications of extracellular vesicles: a report by the NIH Common Fund Extracellular RNA Communication Consortium
Peter J. Quesenberry et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Drug delivery strategies in the therapy of inflammatory bowel disease
Christian Lautenschlaeger et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Colorectal cancer statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Size-controlled biodegradable nanoparticles: Preparation and size-dependent cellular uptake and tumor cell growth inhibition
Jin-Seok Choi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2014)
The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system
Thaher Pelaseyed et al.
IMMUNOLOGICAL REVIEWS (2014)
Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases
H. Ali et al.
JOURNAL OF CONTROLLED RELEASE (2014)
pH-Sensitive Nanoparticles of Curcumin-Celecoxib Combination: Evaluating Drug Synergy in Ulcerative Colitis Model
Dalapathi Gugulothu et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Thergiory Irrazabal et al.
MOLECULAR CELL (2014)
Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases
Aleksandra Piechota-Polanczyk et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs
Abbi R. Saniabadi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Orally administered liposomal formulations for colon targeted drug delivery
Susan Hua
FRONTIERS IN PHARMACOLOGY (2014)
Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease
Rajkumar Malayandi et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)
Overcoming therapeutic obstacles in inflammatory bowel diseases: A comprehensive review on novel drug delivery strategies
F. Talaei et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Production of nanoparticles-in-microparticles by a double emulsion method: A comprehensive study
Yan-Sim Lee et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Geographical variability and environmental risk factors in inflammatory bowel disease
Siew C. Ng et al.
GUT (2013)
Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis
Songwen Ju et al.
MOLECULAR THERAPY (2013)
Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies
Yanlei Ma et al.
PLOS ONE (2013)
Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres
Joshua J. Reineke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
Qilong Wang et al.
NATURE COMMUNICATIONS (2013)
Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease
Bo Xiao et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice
Long Binh Vong et al.
GASTROENTEROLOGY (2012)
Optimization of 5-fluorouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer
Alaa Eldeen B. Yassin et al.
International Journal of Medical Sciences (2012)
5-Fluorouracil-loaded poly(epsilon-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
Raul Ortiz et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)
Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa
Eva-Maria Collnot et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Oral drug delivery research in Europe
Randall J. Mrsny
JOURNAL OF CONTROLLED RELEASE (2012)
Nanoparticle-based clodronate delivery mitigates murine experimental colitis
Wiebke Niebel et al.
JOURNAL OF CONTROLLED RELEASE (2012)
A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue
Elizabeth A. Nance et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Etiology of inflammatory bowel disease: A unified hypothesis
Xiaofa Qin
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
Nicholas J. Talley et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Oral nuclear factor-kappa B decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease
Kohei Tahara et al.
BIOMATERIALS (2011)
Composition and functional role of the mucus layers in the intestine
Malin E. V. Johansson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer
Mayur M. Patel et al.
DRUG DELIVERY (2011)
Intestinal Inflammation and Cancer
Thomas A. Ullman et al.
GASTROENTEROLOGY (2011)
Innate immune mechanisms of colitis and colitis-associated colorectal cancer
Maya Saleh et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery
Kiran Sonaje et al.
BIOMATERIALS (2010)
Characterization of Particle Translocation through Mucin Hydrogels
Oliver Lieleg et al.
BIOPHYSICAL JOURNAL (2010)
Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
R. DUCHMANN et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Photothermal therapy in a murine colon cancer model using near-infrared absorbing gold nanorods
Glenn P. Goodrich et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
Barrier Properties of Gastrointestinal Mucus to Nanoparticle Transport
Jason S. Crater et al.
MACROMOLECULAR BIOSCIENCE (2010)
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Samuel K. Lai et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Barrier properties of mucus
Richard A. Cone
ADVANCED DRUG DELIVERY REVIEWS (2009)
pH-Sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model
Abdallah Makhof et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Curcumin Loaded pH-Sensitive Nanoparticles for the Treatment of Colon Cancer
Dandekar Prajakta et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2009)
Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Benjamin C. Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitis
Brice Moulari et al.
BIOMATERIALS (2008)
Gut instincts: Explorations in intestinal physiology and drug delivery
Emma L. McConnell et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man
Emma L. McConnell et al.
JOURNAL OF CONTROLLED RELEASE (2008)
5-amino salicylic acid bound nanoparticles for the therapy of inflammatory bowel disease
David Pertuit et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer
Lan Li et al.
MOLECULAR CANCER THERAPEUTICS (2007)
In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit FS30D-coated colon-targeted pellets of indomethacin
Chongmin Ji et al.
JOURNAL OF DRUG TARGETING (2007)
Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats
A Lamprecht et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Liposomal formulations of inflammatory bowel disease drugs:: Local versus systemic drug delivery in a rat model
F Kesisoglou et al.
PHARMACEUTICAL RESEARCH (2005)
Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease
U Klotz et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Objective evaluation of small bowel and colonic transit time using pH telemetry in athletes with gastrointestinal symptoms
KA Rao et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2004)
Medication Nonadherence and the outcomes of patients with quiescent ulcerative colitis
S Kane et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study
F Rizzello et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Inflammation and colorectal cancer: IBD-associated and sporadic cancer compared
JM Rhodes et al.
TRENDS IN MOLECULAR MEDICINE (2002)
Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa
A Lamprecht et al.
PHARMACEUTICAL RESEARCH (2001)
Application of a biomagnetic measurement system (BMS) to the evaluation of gastrointestinal transit of intestinal pressure-controlled colon delivery capsules (PCDCs) in human subjects
ZP Hu et al.
PHARMACEUTICAL RESEARCH (2000)
Share Paper
